
|Videos|April 28, 2015
Q&A With Diego Cadavid, MD, FAAN, of Biogen: Anti-Lingo-1 for Optic Neuritis Treatment
Author(s)Adam Hochron
As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.
Advertisement
As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.
Diego Cadavid, MD, FAAN, from Biogen International discussed the effects of Anti-LINGO-1 in the treatment of Acute Optic Neuritis and the results of the RENEW Trial during the American Academy of Neurology's annual meeting in Washington DC.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
5


























































